Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
76 hedge funds and large institutions have $101M invested in Immune Design Corp. in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 16 closing their positions.
191% more call options, than puts
Call options by funds: $239K | Put options by funds: $82K
142% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 12
69% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 16
17% more funds holding
Funds holding: 65 → 76 (+11)
31% less capital invested
Capital invested by funds: $147M → $101M (-$45.6M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$19.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$13.3M |
| 3 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$11M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$8M |
| 5 |
BlackRock
New York
|
+$4.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$10.4M |
| 2 |
DAM
Doheny Asset Management
Los Angeles,
California
|
-$6.33M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.9M |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$1.38M |
| 5 |
Renaissance Technologies
New York
|
-$1.28M |
IMDZ Hedge Fund Activity: Q4 2017 in Review
76 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q4 2017, worth a combined $101M — down 31% from $147M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new IMDZ positions and 16 closed out — a net gain of 11 holders — while 29 added to existing stakes and 12 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $19.4M. The largest seller was Victory Capital Management, cutting an estimated $10.4M.
- 76 institutional investors held Immune Design Corp. (IMDZ) as of Q4 2017, up from 65 in Q3 2017.
- Funds reported $101M of Immune Design Corp. stock for Q4 2017, down 31% quarter-over-quarter.
- 27 funds opened new Immune Design Corp. positions in Q4 2017 and 16 closed out, a net change of +11 holders.
- The largest Immune Design Corp. buyer in Q4 2017 was EcoR1 Capital, an estimated $19.4M added.
- The largest Immune Design Corp. seller in Q4 2017 was Victory Capital Management, an estimated $10.4M sold.
Based on aggregated 13F filings for Q4 2017.